A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression

Clinical trial NCT00429260 · COMPLETED

Trial details

NCT number: NCT00429260
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2007-01-01
Primary completion: 2007-06-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.